Joint with: Antibodies as Drugs: Engineering and Computational Tools Enabling Clinical Advances
Emerging Cell Therapies 2026

February 1-4, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Wendell A. Lim, Ashley K. Koegel and Robbie G. Majzner

  In Person
  On Demand

February 1-4, 2026 | Fairmont Banff Springs, Banff, AB, Canada
Scientific Organizers: Wendell A. Lim, Ashley K. Koegel and Robbie G. Majzner

Available Formats:   = In Person     = On Demand
Sunday, February 1, 2026
Registration
4:00–8:00 PM
Welcome Mixer
6:00–8:00 PM
Monday, February 2, 2026
Breakfast
7:00–8:00 AM
Welcome and Keynote Address
8:00–9:00 AM
New Cell Types for Therapy
8:00–11:00 AM
Ruslan Medzhitov †, HHMI/Yale University School of Medicine
Systems Medicine
Tal Danino †, Columbia University
Bacterial Therapies for Cancer
Yiyin (Erin) Erin Chen †, Broad Institute of MIT and Harvard
Skin Microbiota to Manipulate Immune Responses
Frederick Bennett †, University of Pennsylvania
Microglia Replacement
Oded Rechavi †, Tel Aviv University
Microbial Brain Targeting
Short Talk(s) Chosen from Abstracts
Cell Therapies for Autoimmunity and Inflammation
9:00–11:15 AM
Georg Schett †, Uniklinikum Erlangen
Cell Therapies for Lupus
Ashley K. Koegel, Bristol Myers Squibb
Autoimmune Cell Therapies
Diane Mathis †, Harvard Medical School
TCR Therapies for Autoimmune Disorders
Short Talk(s) Chosen from Abstracts
Coffee Break
9:30–9:50 AM
Poster Setup
11:15–1:00 PM
On Own for Lunch
11:15–5:00 PM
Poster Viewing
1:00–10:00 PM
Coffee Available
4:30–5:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Tuesday, February 3, 2026
Breakfast
7:00–8:00 AM
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Poster Setup
11:00–1:00 PM
Poster Viewing
1:00–10:00 PM
Career Roundtable
3:00–4:30 PM
Coffee Available
4:30–5:00 PM
Cancer Cell Therapies: Preclinical
5:00–7:00 PM
Foundational Synthetic Biology Tools for Cell Engineering
5:00–7:00 PM
Wendell A. Lim, University of California, San Francisco
Cells as Integrators of Complex Functions
Emily Ann Thompson †, Kelonia Therapeutics
in vivo CAR T
Amanda Iniguez †, Moonlight Bio
Cell Therapies using T Cell Tumor Drivers
Robbie G. Majzner, Dana Farber Cancer Institute
Cancer Cell Therapy
Mark Yarmarkovich †, New York University
Peptide Centric CARs
Martin Fussenegger †, ETH Zürich
Therapeutic Cells
Short Talk(s) Chosen from Abstracts
Short Talk(s) Chosen from Abstracts
Social Hour with Lite Bites
7:00–8:00 PM
Posters
7:30–10:00 PM
Wednesday, February 4, 2026
Breakfast
7:00–8:00 AM
Cancer Cell Therapies: Clinical
8:00–11:00 AM
Julie Rytlewski †, Bristol-Myers Squibb
Clinical Data Informing Cell Therapies
Katy Rezvani †, University of Texas MD Anderson Cancer Center
NK Therapies
Marcela V. Maus †, Harvard Medical School
GBM Therapies
Andras Heczey †, Baylor College of Medicine
GPC3 CAR in Liver Cancer
Short Talk(s) Chosen from Abstracts
Coffee Break
9:00–9:20 AM
On Own for Lunch
11:00–5:00 PM
Coffee Available
4:30–5:00 PM
Cell Therapies for Regeneration
5:00–6:45 PM
Douglas A. Melton †, Vertex Pharmaceuticals
Diabetes
Faranak Fattahi †, University of California, San Francisco
Peripheral Nerve Regeneration
Sally Temple †, Neural Stem Cell Institute
Retinal Regen
Short Talk(s) Chosen from Abstracts
Meeting Wrap-Up: Outcomes and Future Directions (Organizers)
6:45–7:00 PM
Social Hour with Lite Bites
7:00–8:00 PM
Cash Bar
8:00–11:00 PM
Entertainment
8:00–11:00 PM
Thursday, February 5, 2026
Departure
12:00–11:59 PM

Subscribe for Updates